These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 196867)

  • 41. Nuclear nonhistone proteins in murine melanoma cells: II. changes following exposure to MSH.
    Wikswo MA; McGuire J; Shansky JE; Boshes RA
    J Invest Dermatol; 1977 Dec; 69(6):516-20. PubMed ID: 411835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Inhibition of human MS and BRO melanoma cell proliferation by alpha melanocyte stimulating hormone].
    Sukhanov VA; Morozova LF; Lalaev VV; Iakh''iaev AV; D'iakov VL
    Vopr Med Khim; 1991; 37(6):73-7. PubMed ID: 1812619
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
    Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
    Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.
    Sawyer TK; Sanfilippo PJ; Hruby VJ; Engel MH; Heward CB; Burnett JB; Hadley ME
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5754-8. PubMed ID: 6777774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endocrine responsiveness in human melanocytes and melanoma cells in culture.
    Fuller BB; Meyskens FL
    J Natl Cancer Inst; 1981 May; 66(5):799-802. PubMed ID: 6262556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting of a chelating derivative of a short-chain analogue of alpha-melanocyte stimulating hormone to Cloudman S91 melanomas.
    Bard DR; Knight CG; Page-Thomas DP
    Biochem Soc Trans; 1990 Oct; 18(5):882-3. PubMed ID: 2128062
    [No Abstract]   [Full Text] [Related]  

  • 47. Insulin-mediated inhibition of tyrosinase activity and protein synthesis in melanoma cell cultures.
    Fuller BB; Ehlers SE
    Endocrinology; 1984 Jan; 114(1):222-6. PubMed ID: 6317345
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro effects of melanocyte-stimulating hormone, adrenocorticotropic hormone, 17 beta-estradiol, or testosterone propionate on Cloudman S91 mouse melanoma cells.
    Cobb JP; McGrath A
    J Natl Cancer Inst; 1974 Feb; 52(2):567-70. PubMed ID: 4361184
    [No Abstract]   [Full Text] [Related]  

  • 49. Polymeric drug-carriers containing doxorubicin and melanocyte-stimulating hormone: in vitro and in vivo evaluation against murine melanoma.
    O'Hare KB; Duncan R; Strohalm J; Ulbrich K; Kopeckova P
    J Drug Target; 1993; 1(3):217-29. PubMed ID: 8069563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors regulating growth and pigmentation of melanoma cells.
    Pawelek JM
    J Invest Dermatol; 1976 Apr; 66(4):201-9. PubMed ID: 178804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Receptors for melanocyte-stimulating hormone on melanoma cells.
    Eberle AN; Siegrist W; Bagutti C; Chluba-De Tapia J; Solca F; Wikberg JE; Chhajlani V
    Ann N Y Acad Sci; 1993 May; 680():320-41. PubMed ID: 8390156
    [No Abstract]   [Full Text] [Related]  

  • 52. [half-Cys4,half-Cys10]-alpha-Melanocyte-stimulating hormone: a cyclic alpha-melanotropin exhibiting superagonist biological activity.
    Sawyer TK; Hruby VJ; Darman PS; Hadley ME
    Proc Natl Acad Sci U S A; 1982 Mar; 79(6):1751-5. PubMed ID: 6281785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. β-Cryptoxanthin suppresses UVB-induced melanogenesis in mouse: involvement of the inhibition of prostaglandin E2 and melanocyte-stimulating hormone pathways.
    Shimoda H; Shan SJ; Tanaka J; Maoka T
    J Pharm Pharmacol; 2012 Aug; 64(8):1165-76. PubMed ID: 22775220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biological activity, binding, and metabolic fate of Ac-[Nle4, D-Phe7]alpha-MSH4-11NH2 with the F1 variant of B16 melanoma cells.
    Panasci LC; McQuillan A; Kaufman M
    J Cell Physiol; 1987 Jul; 132(1):97-103. PubMed ID: 3110178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adenylate cyclase activity in homogenates of human melanoma cells. Effect of alpha-MSH and isoprenaline.
    Karg E; Johansson LH; Hindemith-Augustsson A; Rosengren E; Rorsman H
    Acta Derm Venereol; 1989; 69(4):288-91. PubMed ID: 2568044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stimulation of melanotic expression in murine melanoma cells exposed to polyamine antimetabolites.
    Käpyaho K; Jänne J
    Biochem Biophys Res Commun; 1983 May; 113(1):18-23. PubMed ID: 6407478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of clonogenic growth of melanoma cells by combination of melanocyte stimulating hormone and theophylline.
    Wick MM
    J Invest Dermatol; 1981 Sep; 77(3):253-5. PubMed ID: 7196427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phosphorylated isomers of L-dopa stimulate MSH binding capacity and responsiveness to MSH in cultured melanoma cells.
    McLane J; Osber M; Pawelek JM
    Biochem Biophys Res Commun; 1987 Jun; 145(2):719-25. PubMed ID: 2884996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulatory factors that determine growth and phenotype of normal human melanocytes.
    Herlyn M; Mancianti ML; Jambrosic J; Bolen JB; Koprowski H
    Exp Cell Res; 1988 Dec; 179(2):322-31. PubMed ID: 2461309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormonal regulation of melanogenesis in mouse melanoma and in human melanocytes.
    Fuller BB; Rungta D; Iozumi K; Hoganson GE; Corn TD; Cao VA; Ramadan ST; Owens KC
    Ann N Y Acad Sci; 1993 May; 680():302-19. PubMed ID: 8512220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.